Northwestern University's Richard Silverman and his work leading to the discovery and marketing of Pfizer's blockbuster, Lyrica, are profiled in this Chicago Tribune article. According to Silverman, who took one-fourth of the $700 million in royalties Northwestern made selling a portion of its rights to New York-based Royalty Pharma, finding a billion-dollar drug takes as much scientific curiosity as luck.